SCHEMBL755920

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL752680	0.91	LIPG (0.46)	LIPGLIPC
	SCHEMBL752757	0.78	NPSR1 (0.35)	LIPGALDH1A1EGLN1
	SCHEMBL2778238	0.76	LIPG (0.47)	LIPGLIPC
	SCHEMBL752335	0.75	PTGS2 (0.40)	ALDH1A1RAB9ASMN1; SMN2EGLN1
	SCHEMBL754250	0.75	EGLN1 (0.42)	ALDH1A1SMN1; SMN2EGLN1
	SCHEMBL14259602	0.74	LIPG (0.47)	LIPGLIPC
	SCHEMBL752899	0.73	LIPG (0.51)	LIPGLIPCALDH1A1
	SCHEMBL2490061	0.72	POLB (0.44)	ALDH1A1HTTRAB9ASMN1; SMN2EGLN1
	SCHEMBL751672	0.72	LIPG (0.47)	LIPGLIPCALDH1A1
	SCHEMBL754205	0.72	LIPG (0.47)	LIPGLIPC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.